Home » Medicines Co.’s Bivalirudin Heart Drug Recommended by NICE
Medicines Co.’s Bivalirudin Heart Drug Recommended by NICE
The Medicines Co announced that the National Institute for Health and Clinical Excellence (NICE) has recommended Bivalirudin for treatment of adults with ST-segment-elevation myocardial infarction (STEMI).
RTTNews
RTTNews
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May